| Title |
Omalizumab for asthma in adults and children
|
|---|---|
| Published in |
Cochrane database of systematic reviews, January 2014
|
| DOI | 10.1002/14651858.cd003559.pub4 |
| Pubmed ID | |
| Authors |
Rebecca Normansell, Samantha Walker, Stephen J Milan, E. Haydn Walters, Parameswaran Nair |
X Demographics
The data shown below were collected from the profiles of 30 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Spain | 5 | 17% |
| United Kingdom | 4 | 13% |
| Kuwait | 1 | 3% |
| Israel | 1 | 3% |
| Argentina | 1 | 3% |
| United States | 1 | 3% |
| Ireland | 1 | 3% |
| Colombia | 1 | 3% |
| Unknown | 15 | 50% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 19 | 63% |
| Practitioners (doctors, other healthcare professionals) | 7 | 23% |
| Scientists | 3 | 10% |
| Science communicators (journalists, bloggers, editors) | 1 | 3% |
Mendeley readers
The data shown below were compiled from readership statistics for 653 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 2 | <1% |
| Japan | 2 | <1% |
| Tunisia | 1 | <1% |
| South Africa | 1 | <1% |
| Mexico | 1 | <1% |
| Unknown | 646 | 99% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Master | 84 | 13% |
| Student > Bachelor | 82 | 13% |
| Researcher | 71 | 11% |
| Student > Ph. D. Student | 63 | 10% |
| Other | 41 | 6% |
| Other | 146 | 22% |
| Unknown | 166 | 25% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 258 | 40% |
| Nursing and Health Professions | 40 | 6% |
| Agricultural and Biological Sciences | 26 | 4% |
| Pharmacology, Toxicology and Pharmaceutical Science | 24 | 4% |
| Biochemistry, Genetics and Molecular Biology | 23 | 4% |
| Other | 91 | 14% |
| Unknown | 191 | 29% |
Attention Score in Context
This research output has an Altmetric Attention Score of 39. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 29 October 2023.
All research outputs
#1,060,563
of 26,017,215 outputs
Outputs from Cochrane database of systematic reviews
#2,116
of 13,168 outputs
Outputs of similar age
#11,327
of 326,490 outputs
Outputs of similar age from Cochrane database of systematic reviews
#43
of 246 outputs
Altmetric has tracked 26,017,215 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 95th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 13,168 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 35.9. This one has done well, scoring higher than 83% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 326,490 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 95% of its contemporaries.
We're also able to compare this research output to 246 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 82% of its contemporaries.